David Caldwell
Concepts (340)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Chickens | 28 | 2012 | 110 | 3.170 |
Why?
| Education, Pharmacy | 11 | 2024 | 143 | 3.110 |
Why?
| Students, Pharmacy | 8 | 2019 | 121 | 1.510 |
Why?
| Educational Measurement | 6 | 2019 | 207 | 1.470 |
Why?
| Salmonella | 8 | 2012 | 26 | 1.310 |
Why?
| Meat | 8 | 2011 | 61 | 1.310 |
Why?
| Food Microbiology | 9 | 2011 | 49 | 1.280 |
Why?
| Poultry Diseases | 11 | 2011 | 24 | 1.170 |
Why?
| Food Contamination | 5 | 2012 | 37 | 0.900 |
Why?
| Motor Cortex | 2 | 2020 | 13 | 0.900 |
Why?
| Animal Feed | 4 | 2012 | 56 | 0.890 |
Why?
| Deep Brain Stimulation | 2 | 2020 | 42 | 0.860 |
Why?
| Trichothecenes | 2 | 2012 | 3 | 0.850 |
Why?
| Aflatoxins | 2 | 2012 | 13 | 0.850 |
Why?
| HIV Infections | 3 | 2012 | 357 | 0.810 |
Why?
| Reverse Transcriptase Inhibitors | 2 | 2012 | 5 | 0.760 |
Why?
| Faculty | 2 | 2024 | 72 | 0.730 |
Why?
| Program Evaluation | 3 | 2017 | 354 | 0.670 |
Why?
| Touch Perception | 1 | 2019 | 3 | 0.670 |
Why?
| Somatosensory Cortex | 1 | 2019 | 6 | 0.660 |
Why?
| Evoked Potentials, Somatosensory | 1 | 2019 | 11 | 0.660 |
Why?
| Touch | 1 | 2019 | 25 | 0.660 |
Why?
| Self-Assessment | 1 | 2019 | 46 | 0.660 |
Why?
| Diet | 2 | 2012 | 557 | 0.630 |
Why?
| Coccidiosis | 4 | 2011 | 5 | 0.630 |
Why?
| Writing | 2 | 2022 | 43 | 0.630 |
Why?
| Reaction Time | 1 | 2019 | 216 | 0.620 |
Why?
| Salmonella Infections, Animal | 9 | 2012 | 17 | 0.580 |
Why?
| Salmonella enteritidis | 6 | 2008 | 8 | 0.570 |
Why?
| Education, Distance | 1 | 2017 | 40 | 0.560 |
Why?
| Serum Albumin, Bovine | 3 | 2006 | 22 | 0.560 |
Why?
| Curriculum | 4 | 2019 | 400 | 0.540 |
Why?
| Tissue Engineering | 3 | 2014 | 65 | 0.540 |
Why?
| Antibiotic Prophylaxis | 3 | 2000 | 61 | 0.540 |
Why?
| Pharmaceutical Services | 3 | 2022 | 54 | 0.540 |
Why?
| Chick Embryo | 3 | 2000 | 82 | 0.540 |
Why?
| Peer Review | 1 | 2015 | 9 | 0.520 |
Why?
| Animals | 38 | 2014 | 13246 | 0.520 |
Why?
| Cooperative Behavior | 3 | 2017 | 227 | 0.510 |
Why?
| Peptides | 4 | 2003 | 223 | 0.500 |
Why?
| Antibodies | 2 | 2006 | 154 | 0.490 |
Why?
| Nitriles | 2 | 2012 | 54 | 0.480 |
Why?
| Self Care | 1 | 2015 | 137 | 0.470 |
Why?
| Eimeria | 2 | 2011 | 3 | 0.460 |
Why?
| Electrophoresis, Gel, Two-Dimensional | 2 | 2010 | 37 | 0.450 |
Why?
| Test Taking Skills | 1 | 2013 | 9 | 0.440 |
Why?
| Pyrimidines | 2 | 2012 | 193 | 0.440 |
Why?
| Intestinal Mucosa | 3 | 2004 | 215 | 0.440 |
Why?
| Campylobacter | 2 | 2011 | 5 | 0.440 |
Why?
| Biomimetic Materials | 1 | 2012 | 9 | 0.430 |
Why?
| Chitosan | 1 | 2012 | 34 | 0.420 |
Why?
| Drug Residues | 3 | 2000 | 9 | 0.420 |
Why?
| Biocompatible Materials | 1 | 2012 | 69 | 0.410 |
Why?
| Collagen Type I | 1 | 2012 | 88 | 0.410 |
Why?
| HIV Integrase Inhibitors | 1 | 2012 | 2 | 0.410 |
Why?
| Humans | 28 | 2024 | 50208 | 0.400 |
Why?
| Protozoan Vaccines | 1 | 2011 | 1 | 0.400 |
Why?
| Food Packaging | 1 | 2011 | 7 | 0.390 |
Why?
| Pharmacy | 2 | 2022 | 57 | 0.390 |
Why?
| Quinolones | 1 | 2012 | 39 | 0.380 |
Why?
| Fibroblasts | 1 | 2012 | 351 | 0.360 |
Why?
| Pyridazines | 1 | 2010 | 11 | 0.350 |
Why?
| Poultry | 2 | 2004 | 25 | 0.350 |
Why?
| Anti-HIV Agents | 1 | 2010 | 42 | 0.340 |
Why?
| Cyclohexanes | 1 | 2008 | 4 | 0.330 |
Why?
| Polymerase Chain Reaction | 1 | 2010 | 454 | 0.330 |
Why?
| Dietary Proteins | 1 | 2011 | 239 | 0.320 |
Why?
| Bursa of Fabricius | 4 | 2003 | 5 | 0.310 |
Why?
| Triazoles | 1 | 2008 | 109 | 0.310 |
Why?
| Drug Administration Schedule | 3 | 2012 | 377 | 0.290 |
Why?
| Mast Cells | 2 | 2004 | 52 | 0.290 |
Why?
| Housing, Animal | 2 | 1998 | 15 | 0.290 |
Why?
| Oligodeoxyribonucleotides | 1 | 2006 | 29 | 0.270 |
Why?
| Cecum | 7 | 2011 | 63 | 0.270 |
Why?
| Turkeys | 4 | 2011 | 11 | 0.260 |
Why?
| Immunity, Mucosal | 2 | 2004 | 14 | 0.250 |
Why?
| Water | 2 | 2004 | 75 | 0.250 |
Why?
| Antigens | 1 | 2004 | 41 | 0.240 |
Why?
| Female | 11 | 2024 | 26635 | 0.240 |
Why?
| Anaphylaxis | 2 | 2004 | 71 | 0.240 |
Why?
| Learning | 2 | 2024 | 159 | 0.230 |
Why?
| Male | 11 | 2024 | 25399 | 0.230 |
Why?
| Immunoglobulin G | 4 | 2006 | 186 | 0.230 |
Why?
| Pilot Projects | 3 | 2022 | 697 | 0.210 |
Why?
| Mitogens | 2 | 1999 | 10 | 0.210 |
Why?
| Teaching | 1 | 2024 | 114 | 0.210 |
Why?
| B-Lymphocytes | 2 | 2003 | 170 | 0.210 |
Why?
| Communication | 2 | 2022 | 246 | 0.210 |
Why?
| Crop, Avian | 6 | 2008 | 7 | 0.200 |
Why?
| Job Application | 1 | 2021 | 12 | 0.200 |
Why?
| Students | 1 | 2024 | 211 | 0.200 |
Why?
| Neurosurgery | 1 | 2021 | 32 | 0.190 |
Why?
| Heat Stress Disorders | 1 | 2001 | 9 | 0.190 |
Why?
| Clinical Trials, Phase IV as Topic | 1 | 2021 | 1 | 0.190 |
Why?
| Drug Resistance, Viral | 2 | 2012 | 8 | 0.190 |
Why?
| National Library of Medicine (U.S.) | 1 | 2021 | 4 | 0.190 |
Why?
| Control Groups | 1 | 2021 | 9 | 0.190 |
Why?
| Egg Yolk | 1 | 2000 | 2 | 0.190 |
Why?
| Yolk Sac | 1 | 2000 | 10 | 0.190 |
Why?
| Clinical Trials, Phase III as Topic | 1 | 2021 | 43 | 0.190 |
Why?
| Immunity, Cellular | 1 | 2001 | 70 | 0.190 |
Why?
| Gentamicins | 1 | 2000 | 31 | 0.190 |
Why?
| Subthalamic Nucleus | 1 | 2020 | 13 | 0.180 |
Why?
| Cells, Cultured | 6 | 2014 | 1581 | 0.180 |
Why?
| Cephalosporins | 1 | 2000 | 41 | 0.180 |
Why?
| Faculty, Medical | 1 | 2021 | 92 | 0.180 |
Why?
| Interferon-gamma | 1 | 2001 | 176 | 0.180 |
Why?
| Electric Stimulation | 1 | 2020 | 118 | 0.180 |
Why?
| United States | 8 | 2022 | 4874 | 0.170 |
Why?
| Eimeria tenella | 2 | 2011 | 2 | 0.170 |
Why?
| Artifacts | 1 | 2020 | 54 | 0.170 |
Why?
| Phylogeny | 2 | 2010 | 234 | 0.170 |
Why?
| Time Factors | 8 | 2014 | 2922 | 0.170 |
Why?
| Program Development | 2 | 2017 | 167 | 0.170 |
Why?
| Drug Therapy, Combination | 2 | 2012 | 381 | 0.160 |
Why?
| Prolactin | 1 | 1999 | 44 | 0.160 |
Why?
| Perception | 1 | 2019 | 116 | 0.160 |
Why?
| Pituitary Gland, Anterior | 1 | 1999 | 37 | 0.160 |
Why?
| Dietary Supplements | 2 | 2012 | 434 | 0.160 |
Why?
| Cardiovascular Diseases | 2 | 2021 | 443 | 0.160 |
Why?
| Administration, Oral | 3 | 2006 | 434 | 0.160 |
Why?
| Growth Hormone | 1 | 1999 | 96 | 0.160 |
Why?
| DNA Replication | 1 | 1999 | 150 | 0.160 |
Why?
| Environmental Microbiology | 1 | 1998 | 7 | 0.160 |
Why?
| Protective Clothing | 1 | 1998 | 6 | 0.160 |
Why?
| Parkinson Disease | 1 | 2020 | 151 | 0.160 |
Why?
| Clinical Trials as Topic | 1 | 2020 | 466 | 0.150 |
Why?
| Blood Pressure | 1 | 2020 | 524 | 0.150 |
Why?
| Leukocytes, Mononuclear | 1 | 1998 | 115 | 0.150 |
Why?
| Staff Development | 1 | 2017 | 23 | 0.150 |
Why?
| Bacteriological Techniques | 2 | 1995 | 41 | 0.150 |
Why?
| Databases, Factual | 1 | 2021 | 657 | 0.150 |
Why?
| Achievement | 1 | 2017 | 39 | 0.150 |
Why?
| Professional Role | 1 | 2017 | 76 | 0.150 |
Why?
| Healthcare Disparities | 1 | 2020 | 268 | 0.150 |
Why?
| Leadership | 1 | 2017 | 101 | 0.140 |
Why?
| Disinfectants | 2 | 2011 | 12 | 0.140 |
Why?
| Random Allocation | 5 | 2008 | 282 | 0.130 |
Why?
| Food Deprivation | 5 | 2008 | 30 | 0.130 |
Why?
| Internship and Residency | 1 | 2021 | 441 | 0.130 |
Why?
| Animal Husbandry | 2 | 1999 | 12 | 0.130 |
Why?
| Hypertension | 1 | 2020 | 537 | 0.130 |
Why?
| Serotyping | 2 | 2010 | 12 | 0.120 |
Why?
| Longitudinal Studies | 1 | 2017 | 695 | 0.120 |
Why?
| Osteogenesis | 2 | 2014 | 353 | 0.120 |
Why?
| Retrospective Studies | 2 | 2024 | 6134 | 0.120 |
Why?
| Cell Differentiation | 2 | 2014 | 650 | 0.120 |
Why?
| Cell Survival | 2 | 2014 | 602 | 0.120 |
Why?
| Neovascularization, Physiologic | 1 | 2014 | 68 | 0.120 |
Why?
| Bone Development | 1 | 2014 | 64 | 0.120 |
Why?
| Intestines | 2 | 2006 | 168 | 0.120 |
Why?
| Adult | 5 | 2022 | 13324 | 0.110 |
Why?
| Discriminant Analysis | 1 | 2013 | 27 | 0.110 |
Why?
| Task Performance and Analysis | 1 | 2013 | 52 | 0.110 |
Why?
| Community-Institutional Relations | 1 | 2013 | 46 | 0.110 |
Why?
| Medically Underserved Area | 1 | 2013 | 42 | 0.110 |
Why?
| Injections, Intraperitoneal | 2 | 2004 | 55 | 0.110 |
Why?
| Gene Transfer, Horizontal | 1 | 2012 | 7 | 0.110 |
Why?
| Egg Shell | 1 | 2012 | 1 | 0.110 |
Why?
| Immunization | 2 | 2004 | 67 | 0.110 |
Why?
| Cellular Microenvironment | 1 | 2012 | 26 | 0.110 |
Why?
| Materials Testing | 1 | 2012 | 58 | 0.110 |
Why?
| Endothelial Cells | 1 | 2014 | 270 | 0.100 |
Why?
| Guidelines as Topic | 1 | 2013 | 111 | 0.100 |
Why?
| Drug Resistance, Bacterial | 1 | 2012 | 71 | 0.100 |
Why?
| Cell Proliferation | 2 | 2014 | 1013 | 0.100 |
Why?
| Extracellular Matrix | 1 | 2012 | 111 | 0.100 |
Why?
| Educational Status | 1 | 2013 | 223 | 0.100 |
Why?
| Psychometrics | 1 | 2013 | 224 | 0.100 |
Why?
| Community Pharmacy Services | 1 | 2013 | 67 | 0.100 |
Why?
| Guideline Adherence | 1 | 2013 | 133 | 0.100 |
Why?
| Cell Division | 3 | 2003 | 295 | 0.100 |
Why?
| Brain | 1 | 2020 | 1328 | 0.100 |
Why?
| Spleen | 1 | 2012 | 172 | 0.100 |
Why?
| Escherichia coli | 1 | 2012 | 186 | 0.100 |
Why?
| Roxarsone | 1 | 2011 | 1 | 0.100 |
Why?
| Steroids | 2 | 2003 | 57 | 0.090 |
Why?
| Salmonella enterica | 1 | 2011 | 16 | 0.090 |
Why?
| Injections, Subcutaneous | 2 | 2001 | 54 | 0.090 |
Why?
| Drug Resistance, Microbial | 2 | 2000 | 46 | 0.090 |
Why?
| Osteoblasts | 1 | 2014 | 450 | 0.090 |
Why?
| Abattoirs | 1 | 2010 | 11 | 0.090 |
Why?
| Feces | 1 | 2011 | 131 | 0.090 |
Why?
| DNA, Bacterial | 1 | 2010 | 188 | 0.090 |
Why?
| Weight Gain | 1 | 2011 | 239 | 0.090 |
Why?
| Drinking | 3 | 2004 | 38 | 0.080 |
Why?
| HIV Fusion Inhibitors | 1 | 2008 | 3 | 0.080 |
Why?
| Anti-Retroviral Agents | 1 | 2008 | 14 | 0.080 |
Why?
| Liver | 2 | 2012 | 1116 | 0.080 |
Why?
| Molting | 1 | 2008 | 1 | 0.080 |
Why?
| Cyamopsis | 1 | 2008 | 1 | 0.080 |
Why?
| Kidney | 1 | 2012 | 672 | 0.080 |
Why?
| Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 244 | 0.080 |
Why?
| Immunoglobulin Variable Region | 1 | 2007 | 13 | 0.070 |
Why?
| Antibodies, Protozoan | 1 | 2007 | 12 | 0.070 |
Why?
| Virus Replication | 1 | 2008 | 140 | 0.070 |
Why?
| Transportation | 1 | 2007 | 30 | 0.070 |
Why?
| Antibody Formation | 1 | 2007 | 52 | 0.070 |
Why?
| Sheep | 1 | 2007 | 90 | 0.070 |
Why?
| Immunoglobulin A | 1 | 2006 | 45 | 0.070 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2008 | 550 | 0.070 |
Why?
| Immunoglobulin M | 1 | 2006 | 52 | 0.070 |
Why?
| Stress, Physiological | 1 | 2007 | 170 | 0.070 |
Why?
| Adjuvants, Immunologic | 1 | 2006 | 51 | 0.070 |
Why?
| Disease Susceptibility | 2 | 2008 | 89 | 0.070 |
Why?
| Anti-Bacterial Agents | 1 | 2011 | 747 | 0.060 |
Why?
| Schools, Pharmacy | 2 | 2017 | 54 | 0.060 |
Why?
| Bile | 1 | 2004 | 23 | 0.060 |
Why?
| Immunoglobulin A, Secretory | 1 | 2004 | 6 | 0.060 |
Why?
| Dose-Response Relationship, Drug | 1 | 2006 | 1378 | 0.050 |
Why?
| Online Systems | 1 | 2021 | 8 | 0.050 |
Why?
| Universities | 1 | 2022 | 162 | 0.050 |
Why?
| Oviposition | 1 | 2001 | 10 | 0.050 |
Why?
| Dose-Response Relationship, Immunologic | 1 | 2001 | 13 | 0.050 |
Why?
| Colony Count, Microbial | 1 | 2001 | 66 | 0.050 |
Why?
| Electrophysiology | 1 | 2001 | 78 | 0.050 |
Why?
| Salmonella typhimurium | 1 | 2001 | 48 | 0.050 |
Why?
| Hospitals | 1 | 2022 | 175 | 0.050 |
Why?
| Gastrointestinal Contents | 1 | 2000 | 2 | 0.050 |
Why?
| Bacillus cereus | 1 | 2000 | 5 | 0.050 |
Why?
| Case-Control Studies | 2 | 2001 | 1126 | 0.050 |
Why?
| Chlorides | 1 | 2001 | 50 | 0.050 |
Why?
| Fatty Acids, Volatile | 1 | 2000 | 9 | 0.050 |
Why?
| Seasons | 1 | 2001 | 82 | 0.050 |
Why?
| Pharmacists | 1 | 2022 | 144 | 0.050 |
Why?
| Biological Transport | 1 | 2001 | 172 | 0.050 |
Why?
| Klebsiella pneumoniae | 1 | 2000 | 20 | 0.050 |
Why?
| Lactic Acid | 1 | 2001 | 76 | 0.050 |
Why?
| Glucocorticoids | 1 | 2002 | 226 | 0.040 |
Why?
| Diffusion Tensor Imaging | 1 | 2020 | 91 | 0.040 |
Why?
| Prevalence | 2 | 2020 | 951 | 0.040 |
Why?
| Phorbol 12,13-Dibutyrate | 1 | 1999 | 2 | 0.040 |
Why?
| Recombinant Proteins | 1 | 2001 | 487 | 0.040 |
Why?
| DNA | 2 | 2003 | 541 | 0.040 |
Why?
| Lactose | 1 | 1999 | 9 | 0.040 |
Why?
| Hemolytic Plaque Technique | 1 | 1999 | 2 | 0.040 |
Why?
| Vasoactive Intestinal Peptide | 1 | 1999 | 18 | 0.040 |
Why?
| Length of Stay | 1 | 2022 | 621 | 0.040 |
Why?
| Disinfection | 1 | 1999 | 13 | 0.040 |
Why?
| Phytohemagglutinins | 1 | 1998 | 9 | 0.040 |
Why?
| Analysis of Variance | 1 | 2019 | 564 | 0.040 |
Why?
| Sensitivity and Specificity | 1 | 2000 | 863 | 0.040 |
Why?
| Treatment Outcome | 1 | 2008 | 5155 | 0.040 |
Why?
| Financing, Organized | 1 | 2017 | 13 | 0.040 |
Why?
| Work | 1 | 2017 | 10 | 0.040 |
Why?
| Hospitalization | 1 | 2022 | 655 | 0.040 |
Why?
| Motivation | 1 | 2019 | 273 | 0.040 |
Why?
| Publishing | 1 | 2017 | 39 | 0.040 |
Why?
| Research | 1 | 2017 | 109 | 0.040 |
Why?
| Apoptosis | 1 | 2002 | 1112 | 0.030 |
Why?
| Environmental Monitoring | 1 | 1995 | 65 | 0.030 |
Why?
| Mesenchymal Stem Cell Transplantation | 1 | 2014 | 18 | 0.030 |
Why?
| Evaluation Studies as Topic | 1 | 1994 | 110 | 0.030 |
Why?
| Coculture Techniques | 1 | 2014 | 146 | 0.030 |
Why?
| Cell Communication | 1 | 2014 | 69 | 0.030 |
Why?
| 3T3 Cells | 1 | 2014 | 56 | 0.030 |
Why?
| Cell Size | 1 | 2014 | 45 | 0.030 |
Why?
| Drug Therapy | 1 | 2013 | 46 | 0.030 |
Why?
| Haiti | 1 | 2013 | 4 | 0.030 |
Why?
| Louisiana | 1 | 2013 | 39 | 0.030 |
Why?
| Cell Culture Techniques | 1 | 2014 | 99 | 0.030 |
Why?
| Thinking | 1 | 2013 | 19 | 0.030 |
Why?
| Travel | 1 | 2013 | 37 | 0.030 |
Why?
| Professional-Patient Relations | 1 | 2013 | 47 | 0.030 |
Why?
| Personal Satisfaction | 1 | 2013 | 75 | 0.030 |
Why?
| Escherichia coli Infections | 1 | 2012 | 31 | 0.030 |
Why?
| Collagen | 1 | 2014 | 207 | 0.030 |
Why?
| Cattle | 1 | 2012 | 219 | 0.030 |
Why?
| Rats | 1 | 1998 | 3299 | 0.030 |
Why?
| Ultrasonography | 1 | 2014 | 437 | 0.020 |
Why?
| Calcium | 1 | 2014 | 400 | 0.020 |
Why?
| Gastrointestinal Tract | 1 | 2012 | 101 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 1994 | 905 | 0.020 |
Why?
| Oocysts | 1 | 2011 | 2 | 0.020 |
Why?
| Patient Care Team | 1 | 2013 | 257 | 0.020 |
Why?
| Meat-Packing Industry | 1 | 2011 | 8 | 0.020 |
Why?
| Drug Resistance, Multiple, Bacterial | 1 | 2011 | 63 | 0.020 |
Why?
| Health Promotion | 1 | 2013 | 267 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2014 | 1185 | 0.020 |
Why?
| Clinical Competence | 1 | 2013 | 392 | 0.020 |
Why?
| Attitude of Health Personnel | 1 | 2013 | 351 | 0.020 |
Why?
| Microbial Sensitivity Tests | 1 | 2011 | 270 | 0.020 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2013 | 486 | 0.020 |
Why?
| Photoperiod | 1 | 2008 | 5 | 0.020 |
Why?
| Bacterial Translocation | 1 | 2008 | 16 | 0.020 |
Why?
| Peptide Library | 1 | 2007 | 16 | 0.020 |
Why?
| Antibody Specificity | 1 | 2007 | 36 | 0.020 |
Why?
| Ovary | 1 | 2008 | 115 | 0.020 |
Why?
| Organ Size | 1 | 2008 | 225 | 0.020 |
Why?
| Sequence Alignment | 1 | 2007 | 122 | 0.020 |
Why?
| Middle Aged | 1 | 2022 | 12206 | 0.020 |
Why?
| Disease Models, Animal | 1 | 2012 | 1458 | 0.020 |
Why?
| Ovalbumin | 1 | 2007 | 18 | 0.020 |
Why?
| Animal Welfare | 1 | 2007 | 7 | 0.020 |
Why?
| Blood Urea Nitrogen | 1 | 2007 | 41 | 0.020 |
Why?
| Bilirubin | 1 | 2007 | 40 | 0.020 |
Why?
| Creatinine | 1 | 2007 | 141 | 0.020 |
Why?
| Microscopy, Fluorescence | 1 | 2007 | 166 | 0.020 |
Why?
| Hydrocortisone | 1 | 2007 | 107 | 0.020 |
Why?
| Rest | 1 | 2007 | 63 | 0.020 |
Why?
| Base Sequence | 1 | 2007 | 644 | 0.020 |
Why?
| Amino Acid Sequence | 1 | 2007 | 586 | 0.020 |
Why?
| Molecular Sequence Data | 1 | 2007 | 793 | 0.020 |
Why?
| Vaccination | 1 | 2007 | 271 | 0.020 |
Why?
| Body Weight | 1 | 2007 | 512 | 0.020 |
Why?
| Blood Glucose | 1 | 2007 | 435 | 0.010 |
Why?
| Phorbols | 1 | 2003 | 1 | 0.010 |
Why?
| Mice | 1 | 2014 | 5759 | 0.010 |
Why?
| Immunoglobulin Fc Fragments | 1 | 2003 | 11 | 0.010 |
Why?
| Immunoglobulin Fab Fragments | 1 | 2003 | 16 | 0.010 |
Why?
| Nandrolone | 1 | 2002 | 3 | 0.010 |
Why?
| Lymphocyte Count | 1 | 2002 | 22 | 0.010 |
Why?
| In Situ Nick-End Labeling | 1 | 2002 | 57 | 0.010 |
Why?
| Epithelium | 1 | 2002 | 65 | 0.010 |
Why?
| Proliferating Cell Nuclear Antigen | 1 | 2002 | 75 | 0.010 |
Why?
| Rabbits | 1 | 2003 | 374 | 0.010 |
Why?
| Fluorescein | 1 | 2002 | 8 | 0.010 |
Why?
| Food-Processing Industry | 1 | 2002 | 9 | 0.010 |
Why?
| Animals, Newborn | 1 | 2003 | 368 | 0.010 |
Why?
| Fluorescent Dyes | 1 | 2002 | 106 | 0.010 |
Why?
| Campylobacter Infections | 1 | 2001 | 9 | 0.010 |
Why?
| Hydrogen-Ion Concentration | 1 | 2001 | 176 | 0.010 |
Why?
| Dexamethasone | 1 | 2002 | 430 | 0.010 |
Why?
| Immunohistochemistry | 1 | 2002 | 978 | 0.010 |
Why?
| Potassium Iodide | 1 | 1999 | 1 | 0.010 |
Why?
| Cyclohexenes | 1 | 1999 | 1 | 0.010 |
Why?
| Citric Acid | 1 | 1999 | 16 | 0.010 |
Why?
| Terpenes | 1 | 1999 | 16 | 0.010 |
Why?
| Acetic Acid | 1 | 1999 | 12 | 0.010 |
Why?
| Iodine | 1 | 1999 | 10 | 0.010 |
Why?
| Hippurates | 1 | 1999 | 10 | 0.010 |
Why?
| Chlorhexidine | 1 | 1999 | 11 | 0.010 |
Why?
| Drug Synergism | 1 | 1999 | 151 | 0.010 |
Why?
| Specimen Handling | 1 | 1998 | 55 | 0.010 |
Why?
| Quality Control | 1 | 1998 | 92 | 0.010 |
Why?
| Ethanol | 1 | 1999 | 341 | 0.010 |
Why?
| Propionates | 1 | 1995 | 23 | 0.010 |
Why?
| Skin | 1 | 1998 | 415 | 0.010 |
Why?
| Incidence | 1 | 1997 | 1006 | 0.010 |
Why?
| Muscle, Skeletal | 1 | 1998 | 765 | 0.010 |
Why?
|
|
Caldwell's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|